Re : effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
| Errataetall: |
CommentOn: Clin Microbiol Infect. 2021 Jun;27(6):918-919. - PMID 33129929 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 27(2021), 6 vom: 15. Juni, Seite 920-921 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fiolet, Thibault [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 03.06.2021 Date Revised 07.12.2022 published: Print-Electronic CommentOn: Clin Microbiol Infect. 2021 Jun;27(6):918-919. - PMID 33129929 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cmi.2020.10.031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317343947 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317343947 | ||
| 003 | DE-627 | ||
| 005 | 20231225163052.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cmi.2020.10.031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317343947 | ||
| 035 | |a (NLM)33166647 | ||
| 035 | |a (PII)S1198-743X(20)30662-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fiolet, Thibault |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Re |b effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Clin Microbiol Infect. 2021 Jun;27(6):918-919. - PMID 33129929 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Azithromycin |2 NLM | |
| 650 | 7 | |a 83905-01-5 |2 NLM | |
| 700 | 1 | |a Guihur, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Rebeaud, Mathieu Edouard |e verfasserin |4 aut | |
| 700 | 1 | |a Mulot, Matthieu |e verfasserin |4 aut | |
| 700 | 1 | |a Peiffer-Smadja, Nathan |e verfasserin |4 aut | |
| 700 | 1 | |a Mahamat-Saleh, Yahya |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |d 1995 |g 27(2021), 6 vom: 15. Juni, Seite 920-921 |w (DE-627)NLM094580014 |x 1469-0691 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2021 |g number:6 |g day:15 |g month:06 |g pages:920-921 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmi.2020.10.031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2021 |e 6 |b 15 |c 06 |h 920-921 | ||